Home/Filings/4/0000856982-19-000117
4//SEC Filing

Karras Nolan E. 4

Accession 0000856982-19-000117

CIK 0000856982other

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 7:22 PM ET

Size

19.7 KB

Accession

0000856982-19-000117

Insider Transaction Report

Form 4
Period: 2019-08-16
Transactions
  • Sale

    Common Stock, No Par Value

    2019-08-16$36.46/sh4,000$145,8408,000 total
  • Exercise/Conversion

    Common Stock, No Par Value

    2019-08-16$9.95/sh+8,000$79,60012,000 total
  • Exercise/Conversion

    Non-qualified stock options (right to buy)

    2019-08-168,0008,000 total
    Exercise: $9.95From: 2014-05-22Exp: 2020-05-22Common Stock (8,000 underlying)
Holdings
  • Non-qualified stock options (right to buy)

    Exercise: $20.27From: 2016-05-22Exp: 2022-05-22Common Stock (25,000 underlying)
    25,000
  • Common Stock, No Par Value

    (indirect: By IRA)
    4,000
  • Non-qualified stock options (right to buy)

    Exercise: $13.99From: 2015-06-11Exp: 2021-06-11Common Stock (25,000 underlying)
    25,000
  • Non-qualified stock options (right to buy)

    Exercise: $52.17From: 2020-05-24Exp: 2026-05-24Common Stock (13,750 underlying)
    13,750
  • Common Stock, No Par Value

    (indirect: By Trust)
    2,000
  • Non-qualified stock options (right to buy)

    Exercise: $18.80From: 2017-05-26Exp: 2023-05-26Common Stock (25,000 underlying)
    25,000
  • Non-qualified stock options (right to buy)

    Exercise: $34.40From: 2018-05-24Exp: 2024-05-24Common Stock (25,000 underlying)
    25,000
  • Non-qualified stock options (right to buy)

    Exercise: $50.50From: 2019-06-07Exp: 2025-06-07Common Stock (25,000 underlying)
    25,000
  • Non-qualified stock options (right to buy)

    Exercise: $52.17From: 2020-05-31Exp: 2026-05-31Common Stock (7,500 underlying)
    7,500
Footnotes (9)
  • [F1]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.440 to $36.565, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F2]Becomes exercisable in equal annual installments of 20% commencing 05/22/2014.
  • [F3]Becomes exercisable in equal annual installments of 20% commencing 06/11/2015.
  • [F4]Becomes exercisable in equal annual installments of 20% commencing 05/22/2016.
  • [F5]Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.
  • [F6]Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.
  • [F7]Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.
  • [F8]Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.
  • [F9]Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.

Issuer

MERIT MEDICAL SYSTEMS INC

CIK 0000856982

Entity typeother

Related Parties

1
  • filerCIK 0001534914

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 7:22 PM ET
Size
19.7 KB